Filter
2842
Filtered Results: 2842
Text search:
Drug
Resistance
Featured
Recommendations
301
New Publications
747
Language
Document type
No document type
1636
Studies & Reports
430
Guidelines
425
Manuals
119
Strategic & Response Plan
95
Fact sheets
54
Training Material
41
Situation Updates
15
Infographics
12
Online Courses
5
Resource Platforms
4
Brochures
3
Videos
3
Countries / Regions
India
155
Global
83
South Africa
80
Kenya
79
Western and Central Europe
75
Ethiopia
60
Uganda
51
Nepal
48
Tanzania
48
Eastern Europe
47
Africa
44
Zambia
40
Nigeria
39
Liberia
37
Latin America and the Carribbean
36
Sierra Leone
34
Malawi
32
Philippines
31
Myanmar / Burma
30
Ghana
29
Bangladesh
28
Rwanda
27
Asia
24
Namibia
24
Cambodia
23
Lesotho
22
South–East Asia Region
22
Zimbabwe
20
Ukraine
19
Russia
19
Indonesia
19
Senegal
17
Botswana
14
Congo, Democratic Republic of
13
Cameroon
12
Mozambique
12
Colombia
11
Venezuela
10
Syria
9
Thailand
8
Albania
8
Burkina Faso
8
West and Central Africa
8
Middle East and North Africa
8
Eastern Europe and Central Asia
8
Eswatini/ Swaziland
8
Germany
7
East and Southern Africa
7
Argentina
7
Pakistan
7
Tajikistan
6
USA
6
Haiti
6
Benin
5
China
5
Laos
5
Guinea
5
Vietnam
5
Georgia
5
Peru
4
Western Pacific Region
4
Brazil
4
Sudan
4
Iraq
4
North Macedonia
3
El Salvador
3
Iran
3
Estonia
3
Afghanistan
3
Jordan
3
Paraguay
3
North America
3
Uruguay
3
Lebanon
3
Sri Lanka
3
Central African Republic
3
Bhutan
3
South Sudan
3
Somalia
3
Timor Leste/ East Timor
2
Mexico
2
Morocco
2
Armenia
2
Saudi Arabia
2
Gabon
2
Tunisia
2
Côte d’Ivoire / Ivory Coast
2
Papua New Guinea
2
Moldova
2
Yemen
2
Mali
2
Libya
2
Ecuador
2
Madagascar
2
Switzerland
1
Serbia
1
Turkey
1
Gambia
1
Kazakhstan
1
Canada
1
Fiji
1
Congo-Brazzaville
1
Niger
1
Qatar
1
Italy
1
Guinea-Bissau
1
Turkmenistan
1
Jamaica
1
Denmark
1
Belgium
1
France
1
Maldives
1
Mauritius
1
United Kingdom
1
Spain
1
Bolivia
1
Nicaragua
1
Egypt
1
Romania
1
Greece
1
Honduras
1
Angola
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
997
Clinical Guidelines
311
Public Health
130
Women & Child Health
81
Key Resources
72
Capacity Building
38
Pharmacy & Technologies
37
Annual Report MEDBOX
1
Toolboxes
TB
505
HIV
345
AMR
328
NTDs
119
Mental Health
113
COVID-19
94
Pharmacy
75
Rapid Response
62
Caregiver
49
Planetary Health
48
NCDs
37
Ebola & Marburg
33
Global Health Education
32
Refugee
31
Health Financing Toolbox
20
Polio
17
Conflict
14
Cholera
13
Disability
11
Malaria
11
Natural Hazards
8
Zika
5
Specific Hazards
3
Social Ethics
3
A series of tools and templates have been developed by WHO, FAO and OIE to accompany the manual for developing national action plans on antimicrobial resistance
We systematically reviewed Medline as well as the references of published review articles for relevant studies of adherence to multidrug treatment of both drug-susceptible and drug-resistant TB through February 3, 2018. We included randomized controlled trials (RCTs) as well as prospective and retro...
Following the encouraging initial results of the pilot project, the Ministry of Health is committed to increasing access to MDR-TB diagnosis, treatment and care. An expansion plan for the programmatic management of drug-resistant TB has been developed and forms part of the Five Year National Strateg...
Yaws is targeted for eradication by 2030, using a strategy based on mass drug administration (MDA) with azithromycin. New diagnostics are needed to aid eradication. Serology is currently the mainstay for yaws diagnosis; however, inaccuracies associated with current serological tests makes it difficu...
A view of global supply chains, pressure points, and implications for antimicrobial resistance response
The conditionality of this recommendation is largely driven by the current higher unit cost of pyrethroid-PBO ITNs compared
to pyrethroid-only LLINs and therefore the uncertainty of their cost-effectiveness. Furthermore, as PBO is less wash-resistant
than pyrethroids, its bioavailability declines ...
May 2018
HIV i-Base
ISSN 1475-2077 www.i-Base.info
Watch for out-of-date information
First questions
You and your doctor Resistance and adherence Treatment choices
PlosOne January 20, 2021
https://doi.org/10.1371/journal.pone.0241899
Antibiotic fixed dose combinations (FDCs) can have clinical advantages such as improving effectiveness and adherence to therapy. However, high use of potentially inappropriate FDCs has been reported, with implications for antim...
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
This guide is a resource for physicians and other health care professionals who provide care and treatment to patients with drug-resistant tuberculosis.
The Democratic Republic of Timor-Leste has the highest TB incidence rate in the South East Asian Region - 498 per 100,000, which is the seventh highest in the world. In Timor-Leste TB is the eighth most common cause of death.
The salient observations are as follows:
In 2018, 487 (12.5%) of the...
TB remains one of the world’s deadliest infectious diseases, second only to COVID-19, and drug-resistant TB strains are still a major concern. In the fight against TB, urgent investment is critical, especially in the context of the ongoing pandemic.
hese are two parallel guidelines, one for small hospitals and another one for large hospitals. In view of heavy burden of malaria and prevalence of drug resistant falciparum malaria in the South-East Asia Region, the guidelines were developed for use by medical personnel who treat severe malaria pat...
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi...
The Updated guidelines on Management of tuberculosis in children and adolescents include new recommendations that cover diagnostic approaches for TB, shorter treatment for children with non-severe drug-susceptible TB, a new option for the treatment of TB meningitis, the use of bedaquiline and delama...
Most of the global burden of sepsis occurs in low- and middle-income countries (LMICs), but the prevalence and etiology of sepsis in LMICs are not well understood. In particular, the lack of laboratory infrastructure in many LMICs has historically precluded an assessment of the pathogens leading to ...
Co-trimoxazole is a fixed-dose combination of two antimicrobial drugs (sulfamethoxazole and trimethoprim) that covers a variety of bacterial, fungal and protozoan infections. Co-trimoxazole preventive therapy is a feasible, well tolerated and inexpensive intervention for people living with HIV to re...
sthma prevalence is increasing worldwide, and surveys indicate that most patients in developed and developing countries, including South Africa, do not receive optimal care and are therefore not well controlled. Standard management guidelines adapted to in-country realities are important to support ...
All malaria-endemic countries in the Region of the Americas have taken on the challenge of eliminating malaria and have focused their health programs and strategies on that goal. The risk of emergence of artemisinin resistance in the Americas, the characteristics of P. falciparum parasite, and the e...
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resistant TB (XDRTB) has also been reported from s...
